Effect of a phosphodiesterase inhibitor on cyclic GMP changes induced by muscarinic agonists in mouse neuroblastoma cells [proceedings]
- PMID: 82458
- PMCID: PMC1668540
Effect of a phosphodiesterase inhibitor on cyclic GMP changes induced by muscarinic agonists in mouse neuroblastoma cells [proceedings]
Similar articles
-
Effects of 3-isobutyl-1-methylxanthine and cyclic nucleotides on 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis in vivo.Cancer Res. 1981 Oct;41(10):3918-26. Cancer Res. 1981. PMID: 6169429 No abstract available.
-
Muscarinic agonists have no measurable effect on cGMP formation of rat pinealocytes.Brain Res Bull. 1993;32(6):589-92. doi: 10.1016/0361-9230(93)90159-9. Brain Res Bull. 1993. PMID: 7693307
-
Enhancement by 3-isobutyl-1-methylxanthine and cholera toxin of 12-O-tetradecanoylphorbol-13-acetate-stimulated cyclic nucleotide levels and ornithine decarboxylase activity in isolated epidermal cells.Cancer Res. 1980 Aug;40(8 Pt 1):2653-60. Cancer Res. 1980. PMID: 6155996 No abstract available.
-
Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells.J Pharmacol Exp Ther. 1987 May;241(2):366-73. J Pharmacol Exp Ther. 1987. PMID: 3033212
-
Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.Mol Pharmacol. 1984 Sep;26(2):156-63. Mol Pharmacol. 1984. PMID: 6148690
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources